Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Definitive Healthcare Corp. reported the quarter ended June 30, 2023 results: revenue $61.0 million, net income in the range of $11.4 million to $11.8 million or $(0.08) per share, EPS $(0.08) per share. Guidance reaffirmed.
- Period
- the quarter ended June 30, 2023
- Revenue
- $61.0 million
- Net income
- in the range of $11.4 million to $11.8 million or $(0.08) per share
- EPS
- $(0.08) per share
- Guidance
- reaffirmed
- Result
- preliminary results
Exact text from the filing
Second Quarter 2023 Financial Highlights: • Revenue is expected to be $61.0 million • Net loss is expected to be in the range of $11.4 million to $11.8 million or $(0.08) per share • Adjusted Net Income is expected to be in the range of $12.3 million to $12.4 million or $0.08 per diluted share • Adjusted EBITDA is expected to be $17.2 million
View on SEC.gov
Restructurings & Charges
SEC 8-K Item 2.05/2.06
confidence 0.9
Definitive Healthcare Corp. announced a restructuring with charges of approximately $1.8 million to $2.0 million (42 people, or approximately 4 percent of its total workforce).
- Type
- restructuring
- Charge
- approximately $1.8 million to $2.0 million
- Headcount
- 42 people, or approximately 4 percent of its total workforce
Exact text from the filing
On July 27, 2023, the Company committed to a restructuring plan (the “Plan”) intended to reduce operating costs, improve operating margins, and continue advancing the Company’s ongoing commitment to profitable growth. The Plan provides for a reduction of the Company’s current workforce by 42 people, or approximately 4 percent of its total workforce. The Company estimates that in the third quarter of 2023 it will incur pre-tax cash restructuring and related charges to its GAAP financial results of approximately $1.8 million to $2.0 million, consisting primarily of severance payments, employee benefits, and related cash expenses, as well as a non-cash charge related to the vesting of share-based awards for employees who are terminated.
View on SEC.gov